CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 53 filers reported holding CIDARA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,000 | -99.9% | 1,000 | -99.9% | 0.00% | – |
| Q3 2018 | $3,957,000 | -48.3% | 899,386 | -38.9% | 0.00% | -100.0% |
| Q2 2018 | $7,652,000 | +30.0% | 1,471,553 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,886,000 | -41.2% | 1,471,553 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $10,007,000 | -16.0% | 1,471,553 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $11,920,000 | +8.0% | 1,471,553 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $11,037,000 | -3.8% | 1,471,553 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $11,478,000 | -25.0% | 1,471,553 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $15,304,000 | -4.3% | 1,471,553 | +5.4% | 0.00% | 0.0% |
| Q3 2016 | $15,991,000 | +11.1% | 1,396,553 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $14,398,000 | -34.3% | 1,396,553 | -19.0% | 0.00% | -33.3% |
| Q1 2016 | $21,906,000 | -35.1% | 1,724,850 | -12.3% | 0.00% | -40.0% |
| Q4 2015 | $33,743,000 | +31.2% | 1,966,401 | -2.7% | 0.01% | +25.0% |
| Q3 2015 | $25,710,000 | -9.3% | 2,021,217 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $28,337,000 | – | 2,021,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |